Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

188
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
188
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

257
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
257
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.3K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.3K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

145
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
145
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

116
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
116
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

198
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
198

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cohort profile: Swiss personalized health network cohort consortium.

European journal of epidemiology·2026
Same author

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

The lancet. HIV·2026
Same author

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development.

Cell host & microbe·2026
Same author

Acceptance and preferences for different nicotine substitute products to reduce tobacco smoking in people living with HIV: Results from an internal pilot study of a randomized trial.

Tobacco induced diseases·2026
Same author

Proportional Hazards Regression for Interval-Censored Outcomes With an Interval-Censored Covariate.

Statistics in medicine·2026
Same author

Similar Changes in Proviral Landscapes Over 10 Years in 40 Individuals With Diverging HIV Reservoir Dynamics and Viral Load Kinetics.

Open forum infectious diseases·2026

Related Experiment Video

Updated: May 9, 2025

Growth of Mycobacterium tuberculosis Biofilms
09:03

Growth of Mycobacterium tuberculosis Biofilms

Published on: February 15, 2012

23.7K

Mycobacteria beyond disease.

Terence K Tutumlu1, Cédric Dollé1, Katharina Kusejko2

  • 1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, Zürich, Switzerland.

Trends in Microbiology
|April 29, 2025
PubMed
Summary
This summary is machine-generated.

Mycobacteria exposure may benefit human immunity, modulating allergies and protecting against other infections. These interactions offer potential for new therapies and public health approaches.

Keywords:
allergiesheterologous protectionhost–pathogen interactionsmycobacteria

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography
07:42

Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography

Published on: April 16, 2021

7.7K

Related Experiment Videos

Last Updated: May 9, 2025

Growth of Mycobacterium tuberculosis Biofilms
09:03

Growth of Mycobacterium tuberculosis Biofilms

Published on: February 15, 2012

23.7K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography
07:42

Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography

Published on: April 16, 2021

7.7K

Area of Science:

  • Immunology
  • Microbiology
  • Human Evolution

Background:

  • Mycobacteria have a long evolutionary history with humans.
  • Exposure to mycobacteria can influence the human immune system beyond causing active disease.
  • These interactions may have beneficial, rather than solely pathogenic, effects.

Purpose of the Study:

  • To explore the immunomodulatory effects of mycobacteria exposure.
  • To investigate the potential for mutualistic interactions between humans and mycobacteria.
  • To highlight novel therapeutic and public health applications.

Main Methods:

  • Review of existing literature on mycobacteria-human immune interactions.
  • Analysis of immunomodulatory effects, including allergy and heterologous protection.
  • Exploration of potential therapeutic and public health strategies.

Main Results:

  • Mycobacteria exposure can modulate immune responses, potentially reducing allergies.
  • Exposure may confer heterologous protection against unrelated infections.
  • These effects suggest a complex, potentially beneficial, host-pathogen relationship.

Conclusions:

  • Mycobacteria-human interactions extend beyond disease, offering immune benefits.
  • Understanding these mutualistic relationships can inform novel therapeutic strategies.
  • Harnessing these interactions may lead to advancements in public health and infection control.